Clinical Trials Browser

Phase 2 × Has results × mirvetuximab soravtansine × Clear all

NCT03835819 2026-06-01

A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)

Phase 2 Active not recruiting

18 enrolled 17 charts

Endometrial Neoplasms

NCT05041257 2026-01-09

PICCOLO

Phase 2 Completed

79 enrolled 14 charts

Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms

NCT03106077 2020-12-02

Mirvetuximab Soravtansine as First Line in Treating Patients With Triple Negative Breast Cancer

Phase 2 Completed

96 enrolled 8 charts

Triple Negative Breast Neoplasms